Journal of Biopharmaceutical Statistics最新文献

筛选
英文 中文
Introduction to the special issue Advances in statistical methods for the assessment of patient-centered outcomes. 特刊导论以患者为中心的结果评估的统计方法进展。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-15 DOI: 10.1080/10543406.2025.2472801
Jessica Roydhouse, Nunzio Camerlingo, Joseph C Cappelleri
{"title":"Introduction to the special issue <i>Advances in statistical methods for the assessment of patient-centered outcomes</i>.","authors":"Jessica Roydhouse, Nunzio Camerlingo, Joseph C Cappelleri","doi":"10.1080/10543406.2025.2472801","DOIUrl":"https://doi.org/10.1080/10543406.2025.2472801","url":null,"abstract":"","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1-5"},"PeriodicalIF":1.2,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of EWOC principle in BLRM design for phase 1 oncology trials. 优化肿瘤学 1 期试验 BLRM 设计中的 EWOC 原理。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-04-01 DOI: 10.1080/10543406.2024.2333530
Xiaohan Guo, Sean Kent, Arnab Maity, Wei Zhong
{"title":"Optimization of EWOC principle in BLRM design for phase 1 oncology trials.","authors":"Xiaohan Guo, Sean Kent, Arnab Maity, Wei Zhong","doi":"10.1080/10543406.2024.2333530","DOIUrl":"10.1080/10543406.2024.2333530","url":null,"abstract":"<p><p>Bayesian logistic regression model (BLRM) is widely used to guide dose escalation decisions in phase 1 oncology trials. An important feature of BLRM design is the appealing safety performance due to its escalation with overdose control (EWOC). However, some recent literature indicates that BLRM with EWOC may have a relatively low probability to find the maximum tolerated dose (MTD) compared to some other dose escalation designs. This work discusses this design problem and proposes a practical solution to improve the performance of BLRM design. Specifically, we suggest increasing the EWOC cutoff from routine value 0.25 to a value between 0.3 and 0.4, which will increase the chance of finding the correct MTD with minimal compromise to overdosing risk. Our comparative simulation studies indicate that BLRM with an increased EWOC cutoff has comparable operating characteristics on the correct MTD selection and over-toxicity control as other dose escalation designs (BOIN, mTPI, keyboard, etc.). Moreover, we compare the methodology and operating characteristics of BLRM designs with various decision rules that allow more flexible overdosing control. A case study of dose escalation in a recent phase 1 oncology trial is provided to show how BLRM with optimal EWOC cutoff operates well in practice.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"407-423"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of the medication protocols and longitudinal change of COVID-19 symptoms: a hospital-based mixed-statistical methods study. 用药方案与 COVID-19 症状纵向变化的关联:一项基于医院的混合统计方法研究。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-03-21 DOI: 10.1080/10543406.2024.2333527
Zahra Rezaei Ghahroodi, Samaneh Eftekhari Mahabadi, Alireza Esberizi, Ramin Sami, Marjan Mansourian
{"title":"Association of the medication protocols and longitudinal change of COVID-19 symptoms: a hospital-based mixed-statistical methods study.","authors":"Zahra Rezaei Ghahroodi, Samaneh Eftekhari Mahabadi, Alireza Esberizi, Ramin Sami, Marjan Mansourian","doi":"10.1080/10543406.2024.2333527","DOIUrl":"10.1080/10543406.2024.2333527","url":null,"abstract":"<p><p>The objective of this study was to identify the relationship between hospitalization treatment strategies leading to change in symptoms during 12-week follow-up among hospitalized patients during the COVID-19 outbreak. In this article, data from a prospective cohort study on COVID-19 patients admitted to Khorshid Hospital, Isfahan, Iran, from February 2020 to February 2021, were analyzed and reported. Patient characteristics, including socio-demographics, comorbidities, signs and symptoms, and treatments during hospitalization, were investigated. Also, to investigate the treatment effects adjusted by other confounding factors that lead to symptom change during follow-up, the binary classification trees, generalized linear mixed model, machine learning, and joint generalized estimating equation methods were applied. This research scrutinized the effects of various medications on COVID-19 patients in a prospective hospital-based cohort study, and found that heparin, methylprednisolone, ceftriaxone, and hydroxychloroquine were the most frequently prescribed medications. The results indicate that of patients under 65 years of age, 76% had a cough at the time of admission, while of patients with Cr levels of 1.1 or more, 80% had not lost weight at the time of admission. The results of fitted models showed that, during the follow-up, women are more likely to have shortness of breath (OR = 1.25; P-value: 0.039), fatigue (OR = 1.31; P-value: 0.013) and cough (OR = 1.29; P-value: 0.019) compared to men. Additionally, patients with symptoms of chest pain, fatigue and decreased appetite during admission are at a higher risk of experiencing fatigue during follow-up. Each day increase in the duration of ceftriaxone multiplies the odds of shortness of breath by 1.15 (P-value: 0.012). With each passing week, the odds of losing weight increase by 1.41 (P-value: 0.038), while the odds of shortness of breath and cough decrease by 0.84 (P-value: 0.005) and 0.56 (P-value: 0.000), respectively. In addition, each day increase in the duration of meropenem or methylprednisolone decreased the odds of weight loss at follow-up by 0.88 (P-value: 0.026) and 0.91 (P-value: 0.023), respectively (among those who took these medications). Identified prognostic factors can help clinicians and policymakers adapt management strategies for patients in any pandemic like COVID-19, which ultimately leads to better hospital decision-making and improved patient quality of life outcomes.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"386-406"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140186335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modelling alternately recurring events using subject specific hazard estimation approach. 使用特定主题危害估算方法模拟交替出现的事件。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-03-03 DOI: 10.1080/10543406.2024.2317772
Moumita Chatterjee, Sugata Sen Roy, Bhaswati Ganguli
{"title":"Modelling alternately recurring events using subject specific hazard estimation approach.","authors":"Moumita Chatterjee, Sugata Sen Roy, Bhaswati Ganguli","doi":"10.1080/10543406.2024.2317772","DOIUrl":"10.1080/10543406.2024.2317772","url":null,"abstract":"<p><p>The motivation for this paper is to account for subject specific variations in a Cox proportional hazard model for alternating recurrent events. This is done through two sets of frailty components, whose marginal distributions are bound together by a copula function. The likelihood function involves unobservable variables, which requires the use of the EM algorithm. This leads to intractable integrals, which after some approximations, are solved using computationally intensive techniques. The results are applied to a real-life data. A simulation study is also carried out to check for consistency.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"321-342"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140023352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis application to hERG safety evaluation in clinical trials. 将 Meta 分析应用于临床试验中的 hERG 安全性评估。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-06-14 DOI: 10.1080/10543406.2024.2365972
Xutong Zhao, Jing Sun, Dalong Huang
{"title":"Meta-analysis application to hERG safety evaluation in clinical trials.","authors":"Xutong Zhao, Jing Sun, Dalong Huang","doi":"10.1080/10543406.2024.2365972","DOIUrl":"10.1080/10543406.2024.2365972","url":null,"abstract":"<p><p>One objective of meta-analysis, which synthesizes evidence across multiple studies, is to assess the consistency and investigate the heterogeneity across studies. In this project, we performed a meta-analysis on moxifloxacin (positive control in QT assessment studies) data to characterize the exposure-response relationship and determine the safety margin associated with 10-msec QTc effects for moxifloxacin based on 26 thorough QT studies submitted to the FDA. Multiple meta-analysis methods were used (including two novel methods) to evaluate the exposure-response relationship and estimate the critical concentration and the corresponding confidence interval of moxifloxacin associated with a 10-msec QTc effect based on the concentration-QTc models. These meta-analysis methods (aggregate data vs. individual participant data; fixed effect vs. random effect) were compared in terms of their precision and robustness. With the selected meta-analysis method, we demonstrated the homogeneity and heterogeneity of the moxifloxacin concentration-QTc relationship in studies. We also estimated the critical concentration of moxifloxacin that can be used to calculate the hERG safety margin of this drug.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"343-355"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141321958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Transporting survival of an HIV clinical trial to the external target populations. 关于将 HIV 临床试验的存活率传递给外部目标人群。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-06-29 DOI: 10.1080/10543406.2024.2373437
Hineptch Daungsupawong, Viroj Wiwanitkit
{"title":"Re: Transporting survival of an HIV clinical trial to the external target populations.","authors":"Hineptch Daungsupawong, Viroj Wiwanitkit","doi":"10.1080/10543406.2024.2373437","DOIUrl":"10.1080/10543406.2024.2373437","url":null,"abstract":"","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"465-466"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141472749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to comment on "Transporting survival of an HIV clinical trial to the external target populations by Lee et al. (2024)". 对 "Lee 等人将艾滋病临床试验的存活率转移到外部目标人群(2024 年)"评论的答复。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-07-08 DOI: 10.1080/10543406.2024.2373449
Shu Yang, Xiang Zhang
{"title":"Response to comment on \"Transporting survival of an HIV clinical trial to the external target populations by Lee et al. (2024)\".","authors":"Shu Yang, Xiang Zhang","doi":"10.1080/10543406.2024.2373449","DOIUrl":"10.1080/10543406.2024.2373449","url":null,"abstract":"","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"467-471"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bayesian spatial cluster signal learning with application to adverse event (AE). 贝叶斯空间聚类信号学习在不良事件(AE)中的应用。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-03-21 DOI: 10.1080/10543406.2024.2325148
Hou-Cheng Yang, Guanyu Hu
{"title":"Bayesian spatial cluster signal learning with application to adverse event (AE).","authors":"Hou-Cheng Yang, Guanyu Hu","doi":"10.1080/10543406.2024.2325148","DOIUrl":"10.1080/10543406.2024.2325148","url":null,"abstract":"<p><p>There is growing interest in understanding geographic patterns of medical device-related adverse events (AEs). A spatial scan method combined with the likelihood ratio test (LRT) for spatial-cluster signal detection over the geographical region is universally used. The spatial scan method used a moving window to scan the entire study region and collected some candidate sub-regions from which the spatial-cluster signal(s) will be found. However, it has some challenges, especially in computation. First, the computational cost increased when the number of sub-regions increased. Second, the computational cost may increase if a large spatial-cluster pattern is present and a flexible-shaped window is used. To reduce the computational cost, we propose a Bayesian nonparametric method that combines the ideas of Markov random field (MRF) to leverage geographical information to find potential signal clusters. Then, the LRT is applied for the detection of spatial cluster signals. The proposed method provides an ability to capture both locally spatially contiguous clusters and globally discontiguous clusters, and is manifested to be effective and tractable using hypothetical Left Ventricular Assist Device (LVAD) data as an illustration.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"373-385"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140186336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On approximate equality of Z-values of the statistical tests for win statistics (win ratio, win odds, and net benefit). 关于胜率统计(胜率、胜算和净收益)的 Z 值近似相等的统计检验。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-10-08 DOI: 10.1080/10543406.2024.2374857
Gaohong Dong, Ying Cui, Margaret Gamalo-Siebers, Ran Liao, Dacheng Liu, David C Hoaglin, Ying Lu
{"title":"On approximate equality of Z-values of the statistical tests for win statistics (win ratio, win odds, and net benefit).","authors":"Gaohong Dong, Ying Cui, Margaret Gamalo-Siebers, Ran Liao, Dacheng Liu, David C Hoaglin, Ying Lu","doi":"10.1080/10543406.2024.2374857","DOIUrl":"10.1080/10543406.2024.2374857","url":null,"abstract":"<p><p>Dong et al. (2023) showed that the win statistics (win ratio, win odds, and net benefit) can complement each another to demonstrate the strength of treatment effects in randomized trials with prioritized multiple outcomes. This result was built on the connections among the point and variance estimates of the three statistics, and the approximate equality of Z-values in their statistical tests. However, the impact of this approximation was not clear. This Discussion refines this approach and shows that the approximate equality of Z-values for the win statistics holds more generally. Thus, the three win statistics consistently yield closely similar p-values. In addition, our simulations show an example that the naive approach without adjustment for censoring bias may produce a completely opposite conclusion from the true results, whereas the IPCW (inverse-probability-of-censoring weighting) approach can effectively adjust the win statistics to the corresponding true values (i.e. IPCW-adjusted win statistics are unbiased estimators of treatment effect).</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"457-464"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the use of GEE methods for analyzing binary outcomes in family studies: the Strong Heart Family Study. 评估在家庭研究中使用 GEE 方法分析二元结果的情况:强心家庭研究。
IF 1.2 4区 医学
Journal of Biopharmaceutical Statistics Pub Date : 2025-05-01 Epub Date: 2024-03-29 DOI: 10.1080/10543406.2024.2333516
Xi Chen, Ying Zhang, Amanda M Fretts, Tauqeer Ali, Jason G Umans, Richard B Devereux, Elisa T Lee, Shelley A Cole, Yan Daniel Zhao
{"title":"Assessing the use of GEE methods for analyzing binary outcomes in family studies: the Strong Heart Family Study.","authors":"Xi Chen, Ying Zhang, Amanda M Fretts, Tauqeer Ali, Jason G Umans, Richard B Devereux, Elisa T Lee, Shelley A Cole, Yan Daniel Zhao","doi":"10.1080/10543406.2024.2333516","DOIUrl":"10.1080/10543406.2024.2333516","url":null,"abstract":"<p><p>The generalized estimating equations method (GEE) is commonly applied to analyze data obtained from family studies. GEE is well known for its robustness on misspecification of correlation structure. However, the unbalanced distribution of family sizes and complicated genetic relatedness structure within each family may challenge GEE performance. We focused our research on binary outcomes. To evaluate the performance of GEE, we conducted a series of simulations, on data generated adopting the kinship matrix (correlation structure within each family) from the Strong Heart Family Study (SHFS). We performed a fivefold cross-validation to further evaluate the GEE predictive power on data from the SHFS. A Bayesian modeling approach, with direct integration of the kinship matrix, was also included to contrast with GEE. Our simulation studies revealed that GEE performs well on a binary outcome from families having a relatively simple kinship structure. However, data with a binary outcome generated from families with complex kinship structures, especially with a large genetic variance, can challenge the performance of GEE.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"424-436"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信